Mumbai, India: March 25, 2015 – Sun Pharmaceutical Industries Ltd., begins the integration of Ranbaxy’s business following the successful closure of its merger. The integration, planned by Sun Pharma over many months, will focus on supporting strong growth. Read the full story

Medtronic has completed the acquisition of NGC Medical in a m&a transaction that values NGC at $350 million. Read the full story

UBS analyst Andrew Peters suggested that a recent takeover big in the biotech space of California-based InterMune, Inc.  by Roche was the harbinger of more M&A rumors to come. Read the full story

Medtronic has acquired Sapiens Steering Brain Stimulation, a privately held developer of deep brain stimulation technologies for approximately $200 million in an all-cash m&a transaction. Read the full story

M&A news : Big biotech company, Emergent BioSolutions will acquire Cangene in an all-cash transaction valued at US$222 million Read the full story

In M&A news, Pharmstandard acquires Bever Pharmaceutical for $630 million after spinning out pharmaceutical business. Read the full story

This year has seen a lower frequency in pharma merger and acquisition (M&A) activity with 255 deals announced in the first six months of 2012 compared to 199 deals this year (2013) according to Current Agreements Read the full story

In M&A news, Tenet and Vanguard have signed a definitive agreement whereby Tenet will acquire Vanguard for $21 per share in an all cash transaction. Read the full story

In M&A news, PRA International announced that funds managed by KKR are acquiring PRA International, the clinical research organization (CRO), from Genstar Capital. Read the full story

BTG has entered into an M&A news agreement to buy EKOS Corporation on a debt free cash free basis for an initial cash consideration of approximately US$180 million and up to US$40 million in future milestone payments. Read the full story